MERIDIA
LOE ApproachingNDAORALCAPSULE
Approved
Nov 1997
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
4
Data completeness
3/8 — Basic
Drug data last refreshed 12h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MERIDIA is an oral small-molecule capsule approved in 1997 for weight management, likely a sympathomimetic agent that acts on the central nervous system. The product is currently in loss-of-exclusivity (LOE) approaching phase, indicating mature market status with declining exclusivity protection.
LOE Approaching
With LOE approaching and moderate competitive pressure (30/100), team size is likely contracting; career opportunities focus on managed decline and transition planning rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (4)
MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS)
Started Sep 2020
249 enrolled
Amyotrophic Lateral SclerosisMotor Neuron Disease
An Observational Study to Investigate the Effects of Rapid Transmeridian Travel
Started Sep 2015
119 enrolled
Jet Lag Disorder
Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN)
Started Sep 2006
630 enrolled
Smoking CessationTobacco Use Cessation
A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder
Started Aug 2000
304 enrolled
Binge Eating DisorderObesity
Worked on MERIDIA at Abbott? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.